Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study

BACKGROUND: Cerebrolysin could mitigate reperfusion injury and hemorrhagic transformation (HT) in animal models of acute ischemic stroke. METHODS: This was a prospective, randomized, open-label, parallel-group with active control, multicenter pilot study. Cerebrolysin (30 mL/day over 14 days) was ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Khasanova, Dina R., Kalinin, Mikhail N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041692/
https://www.ncbi.nlm.nih.gov/pubmed/36973684
http://dx.doi.org/10.1186/s12883-023-03159-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041692/
https://www.ncbi.nlm.nih.gov/pubmed/36973684
http://dx.doi.org/10.1186/s12883-023-03159-w

Ejemplares similares